Clinical Significance:

Used for the in vitro quantitative detection of Carcinoembryonic Antigen (CEA) content in human serum, plasma, or whole blood. Clinically, it aids in observing the therapeutic effect of malignant tumors, predicting prognosis, and monitoring recurrence.

Characteristics:

1.Features a wide linear range and excellent reproducibility.

2.Facilitates testing of various sample types, including whole blood, serum, and plasma, thereby enhancing versatility.

3.Boasts a brief assay duration of merely 10 minutes, allowing for swift results.

Registration Certificate Number: 黑械注准 20242400009

Packaging Specifications:

Available in packs of 1, 3, 5, 10, 15, 20, 25, 50, 75, and 100 tests per kit.

Intended Use:

This test kit is designed for the quantitative in vitro measurement of Carcinoembryonic Antigen (CEA) in human serum, plasma, or whole blood. Its clinical applications encompass monitoring the therapeutic effects of malignant tumors, prognostic evaluations, and surveillance for tumor recurrence.